Table 2. HDL3-C, HDL2-C, and total HDL-C levels in various groups of AHF patients.

		HDL3-C (mmol/L)	HDL2-C (mmol/L)	Total HDL-C (mmol/L)	n
Sex	Male	0.48 (0.23–0.85)	0.59 (0.19–1.30)	1.04 (0.42–1.83)	67
	Female	0.50 (0.27–0.82)	0.69 (0.30–1.67)	1.19 (0.57–2.46)	65
		p =0.733	p =0.024	p =0.095
AHF type	De novo	0.54 (0.32–0.85)	0.64 (0.33–1.48)	1.24 (0.70–2.30)	40
	Worsening of CHF	0.46 (0.23–0.79)	0.61 (0.19–1.67)	1.05 (0.42–2.46)	92
		p < 0.001	p =0.115	p =0.017
Sign(s)	No	0.57 (0.33–0.85)	0.62 (0.33–1.25)	1.22 (0.75–2.03)	28
	Yes	0.46 (0.23–0.82)	0.62 (0.19–1.67)	1.09 (0.42–2.46)	104
		p = 0.001	p =0.555	p =0.089
T2D	No	0.51 (0.23–0.82)	0.70 (0.35–1.67)	1.22 (0.63–2.46)	60
	Yes	0.47 (0.23–0.85)	0.59 (0.19–1.09)	1.03 (0.42–1.59)	71
		p =0.210	p = 0.002	p = 0.007
HypChol	No	0.46 (0.23–0.69)	0.62 (0.19–1.44)	1.09 (0.42–1.94)	81
	Yes	0.53 (0.23–0.85)	0.61 (0.30–1.67)	1.21 (0.57–2.46)	51
		p < 0.001	p =0.516	p =0.070
Three months after onset of AHF	Alive	0.51 (0.26–0.85)	0.62 (0.20–1.48)	1.17 (0.46–2.30)	92
	Dead	0.41 (0.23–0.79)	0.55 (0.19–1.67)	0.99 (0.42–2.46)	35
		p < 0.001	p =0.215	p =0.023

Data are presented as median and range (minimum to maximum). Differences in the serum levels of HDL3-C, HDL2-C, and HDL-C between the groups were tested with the Mann-Whitney U test.

P-values of < 0.008 are considered significant after a Bonferroni correction for multiple comparison and are depicted in bold.

AHF, acute heart failure; CHF, chronic heart failure; HDL-C, high-density lipoprotein cholesterol; HypChol, hypercholesterolemia; Signs include enlarged liver, peripheral edemas, ascites and jugular venous distension.